⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2154504 | 0.82 | KMT2A (0.47) | — | |
| SCHEMBL242038 | 0.82 | FFAR1 (0.42) | — | |
| SCHEMBL242001 | 0.76 | MEN1 (0.56) | — | |
| SCHEMBL745687 | 0.76 | — | — | |
| SCHEMBL23137321 | 0.74 | MMP3 (0.50) | — | |
| SCHEMBL1921814 | 0.74 | — | — | |
| SCHEMBL37831 | 0.74 | — | — | |
| SCHEMBL8763328 | 0.74 | KMT2A (0.42) | — | |
| SCHEMBL1332411 | 0.74 | — | — | |
| Benzene SCHEMBL7517467 | 0.74 | ENPP2 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 872 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365557-A1 | IMIDAZOPYRIDINYL COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | 1ST Biotherapeutics, Inc. (KR) | 2023-11-16 | — | — | US | claimed |
| US-11802126-B2 | Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders | 1ST Biotherapeutics, Inc. (KR) | 2023-10-31 | — | — | US | claimed |
| CN-113004278-B | Bicyclic heterocycles as FGFR inhibitors | 因赛特控股公司 | 2023-07-21 | — | — | CN | claimed |
| EP-3692023-B1 | BENZOTHIAZOL COMPOUNDS AND METHODS USING THE SAME FOR TREATING NEURODEGENERATIVE DISORDERS | 1ST BIOTHERAPEUTICS INC (KR) | 2023-05-17 | — | — | EP | claimed |
| US-20220389009-A1 | SUBSTITUTED 1,6-NAPHTHYRIDINE INHIBITORS OF CDK5 | GFB (ABC), LLC | 2022-12-08 | — | — | US | claimed |
| CN-114761000-A | Substituted 1, 6-naphthyridine inhibitors of CDK5 | 金翅雀生物公司 | 2022-07-15 | — | — | CN | claimed |
| EP-4011353-A1 | NEW COSMETICS SOLVENTS COMPRISING ASCORBIC ACID | Beiersdorf AG (DE) | 2022-06-15 | — | — | EP | claimed |
| EP-4011354-A1 | NEW COSMETICS SOLVENTS BASED ON TWO DIFFERENT COMPONENTS | Beiersdorf AG (DE) | 2022-06-15 | — | — | EP | claimed |
| EP-4011352-A1 | NEW COSMETICS SOLVENTS BASED ON THREE DIFFERENT COMPONENTS | Beiersdorf AG (DE) | 2022-06-15 | — | — | EP | claimed |
| WO-2022011274-A1 | SUBSTITUTED 1,6-NAPHTHYRIDINE INHIBITORS OF CDK5 | GOLDFINCH BIO, INC. (US) | 2022-01-13 | — | — | WO | claimed |
| EP-0910565-A1 | AMIDE DERIVATIVES AS SELECTIVE NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | Bayer Corporation (US) | 1999-04-28 | — | — | EP | claimed |
| WO-1999002510-A1 | MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN S.P.A. (IT) | 1999-01-21 | — | — | WO | claimed |
| WO-1998035957-A1 | AMIDE DERIVATIVES AS SELECTIVE NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | BAYER CORPORATION (US) | 1998-08-20 | — | — | WO | claimed |
| US-5593975-A | Adenosine derivatives having A2 agonist activity | SCHERING CORPORATION (US) | 1997-01-14 | — | — | US | claimed |
| WO-1993022328-A1 | ADENOSINE DERIVATIVES HAVING A2 AGONIST ACTIVITY | SCHERING-PLOUGH S.P.A. (IT) | 1993-11-11 | — | — | WO | claimed |
| EP-0512020-A1 | PROCESS FOR PREPARING HOMOCHIRAL AMINES AND PROCESS FOR PREPARING INTERMEDIATES FOR THE PREPARATION THEREOF | Nobel Chemicals AB (SE) | 1992-11-11 | — | — | EP | claimed |
| WO-1991010642-A1 | PROCESS FOR PREPARING HOMOCHIRAL AMINES AND PROCESS FOR PREPARING INTERMEDIATES FOR THE PREPARATION THEREOF, AND THE INTERMEDIATES PREPARED IN ACCORDANCE WITH THIS PROCESS | NOBEL CHEMICALS AB (SE) | 1991-07-25 | — | — | WO | claimed |
| CN-1042153-A | 3-aryloxy methyl-cephalosporins derivatives, their preparation and purposes pharmaceutically | SANKYO CO (JP) | 1990-05-16 | — | — | CN | claimed |
| EP-0363223-A2 | 3-Aryloxymethyl-cephalosporin derivatives, their preparation and their medical use | Sankyo Company Limited (JP) | 1990-04-11 | — | — | EP | claimed |
| EP-0000599-A1 | Electrically photosensitive particles for photoelectrophoretic migration imaging processes | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1979-02-07 | — | — | EP | claimed |